Alexion
121 Seaport Blvd Boston
Boston
MA
02210
United States
Tel: 475-230-2596
Website: http://www.alexion.com/
About Alexion
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.
Company Ownership: Public
Stock Symbol: AZN
Stock Exchange: Nasdaq
715 articles with Alexion
-
Alexion Pharmaceuticals Inc. Invites You To Participate In A Conference Call And Web Cast
1/26/2006
-
Alexion Pharmaceuticals Inc. Completes Patient Treatment In Its Phase III Pivotal TRIUMPH Efficacy Trial Of Eculizumab In PNH Patients
1/4/2006
-
Alexion Pharmaceuticals Inc. To Present At The 24th Annual JP Morgan Healthcare Conference
1/3/2006
-
Alexion Pharmaceuticals Inc. Reports Three-Year Cumulative Clinical Data Of Eculizumab Therapy In Patients With Paroxysmal Nocturnal Hemoglobinuria
12/12/2005
-
Alexion Pharmaceuticals Inc. Release: Researchers Identify Pulmonary Hypertension As New, Previously Unrecognized Morbidity Of Paroxysmal Nocturnal Hemoglobinuria (PNH)
12/12/2005
-
Alexion Pharmaceuticals Inc. Reports First Quarter 2006 Results
12/6/2005
-
Alexion Pharmaceuticals Inc. Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations
11/23/2005
-
Alexion Pharmaceuticals Inc. Forms Alexion Europe SAS
11/8/2005
-
Alexion Pharmaceuticals Inc. To Present At SG Cowen & Co., LLC 6th Annual Global Health Care Conference
11/2/2005
-
Alexion Pharmaceuticals Inc. To Present At Bear Stearns Mid-Cap Investor Conference
10/31/2005
-
Drug Could Cut Heart Surgery Risks
9/9/2005
-
Yale, Brigham and Women's Hospital, And Alexion Report Potential New Treatment For Asthma
5/13/2005
-
Alexion Pharmaceuticals Inc. To Present At The Smith Barney Citigroup 2005 Healthcare Conference
3/24/2005
-
Alexion Pharmaceuticals Inc. To Present At The Smith Barney Citigroup 2005 Small And Mid-Cap Conference
2/10/2005
-
Alexion Pharmaceuticals Inc. To Present At The 22nd Annual JP Morgan Healthcare Conference
1/7/2004